Giovanni Morana

Summary

Affiliation: Institute of Infectious Diseases and Public Health
Country: Italy

Publications

  1. ncbi Contrast agents for hepatic magnetic resonance imaging
    Giovanni Morana
    Radiological Department, University of Verona, Verona, Italy
    Top Magn Reson Imaging 13:117-50. 2002
  2. ncbi Contrast agents for hepatic MRI
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 7:S24-7. 2007
  3. ncbi Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA
    Giovanni Morana
    Department of Radiology, University of Verona, Italy
    Acad Radiol 9:S476-9. 2002
  4. ncbi Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 8:S132-5. 2008
  5. ncbi Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging
    Alessandro Guarise
    Radiological Department, General Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 8:220-8. 2008
  6. ncbi Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse
    Franco Capra
    Department of Biomedical and Surgical Sciences, Internal Medicine A, University of Verona, Verona, Italy
    Dig Dis Sci 50:1535-7. 2005
  7. ncbi Autoimmune pancreatitis: instrumental diagnosis
    Giovanni Morana
    Radiological Department, Hospital Ca' Foncello, Treviso, Italy
    JOP 6:102-7. 2005
  8. ncbi Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography
    Riccardo Lencioni
    Department of Radiology, University of Pisa, Pisa, Italy
    Dig Dis Sci 50:533-7. 2005
  9. ncbi Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study
    Luigi Grazioli
    Department of Radiology, University of Brescia, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25023 Brescia, Italy
    Radiology 236:166-77. 2005
  10. ncbi Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging
    Gunther Schneider
    Department of Diagnostic and Interventional Radiology, University Hospital, Homburg Saar, Germany
    Invest Radiol 42:105-15. 2007

Collaborators

Detail Information

Publications19

  1. ncbi Contrast agents for hepatic magnetic resonance imaging
    Giovanni Morana
    Radiological Department, University of Verona, Verona, Italy
    Top Magn Reson Imaging 13:117-50. 2002
    ..To understand contrast behavior after injection of LSCM, it is necessary to correlate contrast enhancement with the biologic and histologic findings of FLL...
  2. ncbi Contrast agents for hepatic MRI
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 7:S24-7. 2007
    ..To understand the contrast behaviour after injection of LSCM it is necessary to correlate the contrast enhancement with both the biological and histological findings of FLL...
  3. ncbi Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA
    Giovanni Morana
    Department of Radiology, University of Verona, Italy
    Acad Radiol 9:S476-9. 2002
  4. ncbi Small liver lesions in oncologic patients: characterization with CT, MRI and contrast-enhanced US
    Giovanni Morana
    Radiological Department, General Hospital Ca Foncello, Piazza Ospedale 1, 31100 Treviso, Italy
    Cancer Imaging 8:S132-5. 2008
    ..Moreover, the continuous follow-up of cancer patients requires an easily available, reliable and cost-effective diagnostic tool for the detection and characterization of FLLs...
  5. ncbi Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging
    Alessandro Guarise
    Radiological Department, General Hospital Ca Foncello, Treviso, Italy
    Cancer Imaging 8:220-8. 2008
    ..No cystic lesion showed changes in morphology and structure. Branch duct IPMNs smaller than 3 cm, without associated filling defects, tend to be stable, making 'watch and wait' management possible...
  6. ncbi Vanishing bile duct syndrome and inflammatory pseudotumor associated with a case of anabolic steroid abuse
    Franco Capra
    Department of Biomedical and Surgical Sciences, Internal Medicine A, University of Verona, Verona, Italy
    Dig Dis Sci 50:1535-7. 2005
  7. ncbi Autoimmune pancreatitis: instrumental diagnosis
    Giovanni Morana
    Radiological Department, Hospital Ca' Foncello, Treviso, Italy
    JOP 6:102-7. 2005
  8. ncbi Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography
    Riccardo Lencioni
    Department of Radiology, University of Pisa, Pisa, Italy
    Dig Dis Sci 50:533-7. 2005
    ..0167). Ferucarbotran-enhanced MR imaging is superior to spiral CT in clinical management of patients with suspected hepatic malignancy...
  9. ncbi Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study
    Luigi Grazioli
    Department of Radiology, University of Brescia, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25023 Brescia, Italy
    Radiology 236:166-77. 2005
    ..To prospectively determine the accuracy of differentiating benign focal nodular hyperplasia (FNH) from hepatic adenoma (HA) and liver adenomatosis (LA) by using gadobenate dimeglumine-enhanced magnetic resonance (MR) imaging...
  10. ncbi Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging
    Gunther Schneider
    Department of Diagnostic and Interventional Radiology, University Hospital, Homburg Saar, Germany
    Invest Radiol 42:105-15. 2007
    ..We sought to evaluate gadobenate dimeglumine for the detection and characterization of focal liver lesions in the unenhanced and already pre-enhanced liver...
  11. ncbi Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT
    Carlo Bartolozzi
    Department of Radiology, University of Pisa, Via Roma 67, 56100, Pisa, Italy
    Eur Radiol 14:14-20. 2004
    ..0023) and unenhanced MRI (21 of 44 cases, p=0.0013). MnDPDP-enhanced MRI is superior to unenhanced MRI and spiral CT in the detection of hepatic colorectal metastases...
  12. ncbi MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison
    Luigi Grazioli
    Department of Radiology, University of Brescia, Brescia, Italy
    J Magn Reson Imaging 17:593-602. 2003
    ..To compare the efficacy of two different MR contrast agents for the detection and diagnosis of focal nodular hyperplasia (FNH)...
  13. ncbi Renal artery stenosis evaluation: diagnostic performance of gadobenate dimeglumine-enhanced MR angiography--comparison with DSA
    Gilles Soulez
    Department of Radiology, Centre Hospitalier de l Universite de Montreal, University of Montreal, 1560 Sherbrooke East, Montreal, QC, Canada H2V 2Z2
    Radiology 247:273-85. 2008
    ..1 mmol per kilogram of body weight gadobenate dimeglumine for depiction of significant steno-occlusive disease (> or =51% stenosis) of renal arteries, with digital subtraction angiography (DSA) as reference standard...
  14. ncbi The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography
    Henrik S Thomsen
    Department of Diagnostic Radiology, Copenhagen University Hospital, Herlev, Denmark
    Invest Radiol 43:170-8. 2008
    ....
  15. ncbi Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial
    Siegfried Thurnher
    Department of Radiology and Nuclear Medicine, Hospital Brothers of St John of God, Grosse Mohrengasse 9, Vienna, Austria A 1020
    AJR Am J Roentgenol 189:1223-37. 2007
    ....
  16. ncbi Whole-body magnetic resonance angiography with blood-pool agents
    Harald Kramer
    Institute for Clinical Radiology, University Hospital Munich, Marchioninstrasse 15, 81377 Munich, Germany
    Eur Radiol 17:B24-9. 2007
    ....
  17. ncbi Tumors of the spine in children
    Andrea Rossi
    Department of Pediatric Neuroradiology, G Gaslini Children s Hospital, Largo G Gaslini 5, I 16147 Genoa, Italy
    Neuroimaging Clin N Am 17:17-35. 2007
    ..Magnetic resonance imaging provides crucial information regarding the extent, location, and internal structure of the mass, thus critically narrowing the differential diagnosis and guiding surgery...
  18. ncbi Contrast agents in abdominal imaging: current and future directions
    Gunther Schneider
    Department of Diagnostic and Interventional Radiology, University Hospital of Saarland, Homburg Saar, Germany
    Top Magn Reson Imaging 16:107-24. 2005
    ..The availability of orally administered MR contrast agents has further extended the range of abdominal applications, making MR imaging of the small bowel and the colon established imaging procedures...
  19. ncbi Prenatal MR imaging of dural sinus malformation: a case report
    Andrea Rossi
    Department of Pediatric Neuroradiology, G Gaslini Children s Hospital, Genoa, Italy
    Prenat Diagn 26:11-6. 2006
    ..To describe prenatal magnetic resonance imaging (MRI) findings of dural sinus malformation (DSM), a very rare, congenital form of dural arteriovenous shunt (DAVS), typically affecting newborns...